Tata MD & ADL partner to transform COVID testing
The Pioneer Hyderabad 24th March
Tata Medical and I Diagnostics (Tata MD) has collaborated with city-based Anderson Diagnostics and Labs to standardise the indigenously developed diagnostic kit Tata MD CHECK in a bid to slow down the rate of new COVID-19 infections. This is part of a wide ranging clinical collaboration between the two companies. The 'Made-in-India' Tata MD CHECK diagnostic kit can be scaled rapidly with Anderson Diagnostics Labs having already successfully conducted over 10,000 COVID-19 tests, using the DGCA approved Indian Council of Medical Research guidelines, novel diagnostic solution based on Feluda CRISPR Platform, a company statement said. "Tata's CRISPR-based platform is a rock-solid COVID test that can be programmed for early detection and treatment of a number of other diseases and conditions as well," Anderson Diagnostics and Labs Director Dr Srinivasaraman said.